The Fungal Infection Trust has been supporting research directly or indirectly through its LIFE program. The many papers published as a result of the FITs support since 2003 are listed below by year.
We are currently updating the links to some of the published papers listed. We apologise for any inconvenience if the link to a paper you are looking for is not yet functioning.
Publications supported by the Fungal Infection Trust 2022
Denning DW. Antifungal resistance – update. Eur J Hosp Pharm 2022;29:109-112.
Agudelo Higuita NI, Varela Bustillo D, Denning DW.Burden of Serious Fungal Infections in Honduras. Mycoses 2022;65:429-439.
Lmimouni BE, Hennequin C, Penney ROS, Denning DW.Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco. J Fungi (Basel) 2022;8(4):414.
Colombo SAP, Hashad R, Denning DW, Kumararatne DS, Ceron-Gutierrez L, Barcenas-Morales G, MacDonald AS, Harris C, Doffinger R, Kosmidis C.Defective IFNγ production in chronic pulmonary aspergillosis is correlated with increased mortality. J Infect Dis 2022;225:1822-31.
Werkneh S. Orefuwa E, Denning DW.Serious fungal disease incidence and prevalence in Eritrea.Mycoses 2022;65:806-14.
Kuate MPN, Abessolo Abessolo H, Denning DW, Stone NR, Ndip RN.Diagnosing disseminated histoplasmosis in advanced HIV/AIDS disease in Cameroon using a point of care lateral flow assay. Ther Adv Infect Dis 2022;9:20499361221132133.
Doumbo SN, Cissoko Y, Dama S, Niangaly A, Garango A, Konaté A, Koné A, Traoré B, Thera M, Djimde A, Denning DW.Incidence and prevalence of fungal diseases in Mali. J Med Mycol 2023;33:101333.
Denning DW, Morgan EF.Quantifying deaths from aspergillosis in HIV positive people. J Fungi 2022;8:1131.
Ray A, Adarsh AK, Banerjee S, Chakrabarti A, Denning DW.Burden of serious fungal infections in India. Open Forum Infect Dis 2022; 9(12): ofac603.
Denning DW, Cole DC, Ray A.New estimation of chronic pulmonary aspergillosis (CPA) related to pulmonary TB – revised burden for India. Int J Infect Dis Regions 2022;6:7-14.
Dr Felix Bongomin, Gulu University, Uganda
Prevalence & Factors Associated with Acute Disseminated Histoplasmosis in Patients with Advanced HIV
Dr Nyla P Lyons, MRF Trinidad & Tobago
Assessing the Risk Factors for Disseminated Histoplasmosis among Persons Living with Advanced HIV
Dr Christine Mandengue, Universite des Montagnes, Bangante, Cameroon
Diagnostic of disseminated histoplasmosis on urine in patients with advanced HIV
Prof. Teresa Zelante, University of Perugia, Italy
Evaluating Aspergillus fumigatus in host adaptation using animal models of pulmonary disease
Dr. M Ameyo Dorkenoo, University of Lome, Togo
Prevalence of pneumocystis pneumonia and pulomary Aspergillosis
Kuate Ngouanom Marious Paulin, Cameroon
Histoplasmosis and Tuberculosis Coinfection amongst HIV positive and HIV negative patients in Yaoundé, Cameroon
Dr Animesh Ray, All India Medical Institute, Delhi
A study on genetic defects predisposing to Chronic pulmonary aspergillosis from a North Indian tertiary referral centre
Pocha Samuel Kamudumuli, Kamuzu University of Health Sciences, Malawi
Determining prevalence of Histoplasmosis and Aspergillosis in Malawi and feasibility of usage of Histoplasma Capsule Urinary Diagnostic Rapid Test – OIDX on in-patients and Aspergillus ICT lateral flow assay on advanced HIV Disease.
Dr Jacob Baker, Medical Research Foundation of Trindad & Tobago
Investigating for concurrent or misdiagnosed fungal pulmonary infection in suspected pulmonary tuberculosis in Trinidad and Tobago.